Loading clinical trials...
Loading clinical trials...
Cyclin kinase inhibitor P16INK4A has overexpression in cervical cancer, and hence becoming an alternative method for cervical cancer screening. This study is to investigate the clinical value of P16IN...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lei Li
NCT07181278 · Cervical Cancer Screening, HIV
NCT05390567 · Cervical Cancer Screening Methods
NCT06995157 · Cervical Cancer Screening, Vaccination Uptake
NCT06915610 · Cervical Cancer Screening
NCT06931184 · Cervical Cancer Screening
Lei Li
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions